| Q24533465 | A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. |
| Q35674768 | A structural perspective on the regulation of the epidermal growth factor receptor |
| Q28305519 | ADAMs: key components in EGFR signalling and development |
| Q44460129 | Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. |
| Q35058437 | Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases |
| Q28209976 | Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity |
| Q36938534 | Biological function of nuclear receptor tyrosine kinase action |
| Q36274343 | Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. |
| Q28344424 | Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme |
| Q80818417 | Control of EGF receptor activation in Drosophila |
| Q80282010 | Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains |
| Q34590284 | Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia |
| Q29619032 | EGF-ERBB signalling: towards the systems level |
| Q44517519 | Ectodomain cleavage of ErbB-4: characterization of the cleavage site and m80 fragment |
| Q37879318 | Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands |
| Q37353696 | Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients |
| Q39136071 | ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains |
| Q34583143 | ErbB-4: a receptor tyrosine kinase |
| Q28578116 | ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration |
| Q36095732 | ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis |
| Q35740039 | ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response |
| Q24314345 | Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes |
| Q24531403 | Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. |
| Q39301423 | Flotillins as regulators of ErbB2 levels in breast cancer |
| Q40587910 | Gene expression profiling of ErbB receptor and ligand-dependent transcription |
| Q54737143 | HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissue. |
| Q37169043 | HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR. |
| Q34048293 | HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4. |
| Q34013847 | Heparin-binding EGF-like growth factor: a juxtacrine growth factor |
| Q57371902 | Heregulin-dependent Trafficking and Cleavage of ErbB-4 |
| Q34314907 | Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription |
| Q74450227 | Immune responses to all ErbB family receptors detectable in serum of cancer patients |
| Q28767062 | Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis |
| Q30840561 | Kinase peptide specificity: improved determination and relevance to protein phosphorylation |
| Q35340703 | Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3 |
| Q37743354 | Mechanistic insights into ectodomain shedding: susceptibility of CADM1 adhesion molecule is determined by alternative splicing and O-glycosylation. |
| Q52537021 | NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. |
| Q24644225 | Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells |
| Q33796246 | New paradigms of signaling in the vasculature: ephrins and metalloproteases |
| Q35089368 | Nuclear localization and possible functions of receptor tyrosine kinases |
| Q34612339 | Presenilin-1 processing of ErbB4 in fetal type II cells is necessary for control of fetal lung maturation. |
| Q40357721 | Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth |
| Q36113481 | Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases |
| Q37472880 | Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity. |
| Q26830216 | Receptor tyrosine kinases in the nucleus |
| Q35942587 | Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons |
| Q33403045 | Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor. |
| Q40494875 | Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling |
| Q57374322 | Role of gangliosides in the association of ErbB2 with lipid rafts in mammary epithelial HC11 cells |
| Q42528205 | Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage |
| Q40403940 | Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment |
| Q39478403 | Selective cleavage of ErbB4 by G-protein-coupled gonadotropin-releasing hormone receptor in cultured hypothalamic neurons |
| Q39372364 | Sequential proteolytic processing of an interferon-alpha receptor subunit by TNF-alpha converting enzyme and presenilins |
| Q39953010 | Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells |
| Q41967579 | Signalling-competent truncated forms of ErbB2 in breast cancer cells: differential regulation by protein kinase C and phosphatidylinositol 3-kinase |
| Q26750970 | Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance |
| Q40891936 | Stimulation of cleavage of membrane proteins by calmodulin inhibitors |
| Q83200641 | Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms |
| Q28511737 | The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation |
| Q38598710 | The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors |
| Q37135372 | The ERBB3 receptor in cancer and cancer gene therapy |
| Q41738022 | The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands |
| Q46709835 | The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase |
| Q34048265 | The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation |
| Q83150764 | The developing role of receptors and adaptors |
| Q35357793 | The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines |
| Q24314999 | The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity |
| Q35107643 | The evolving roles of cell surface proteases in health and disease: Implications for developmental, adaptive, inflammatory, and neoplastic processes |
| Q33692379 | The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes |
| Q24676816 | The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses |
| Q34493341 | The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis |
| Q28678514 | The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor |
| Q37326973 | The role of protease activity in ErbB biology |
| Q44691513 | The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. |
| Q38320220 | The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading |
| Q33538424 | The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer |
| Q37308472 | Trafficking of receptor tyrosine kinases to the nucleus |
| Q41739829 | Transforming the cell surface through proteolysis |
| Q34584816 | Transmodulation of cell surface regulatory molecules via ectodomain shedding |
| Q28609073 | Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4 |
| Q42540708 | Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. |
| Q36621288 | c-erbB-4 protein expression in human breast cancer |